Recursion Pharmaceuticals Inc RXRX Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	701.29M	627.37M	666.7M	630.83M	653.7M	557.85M	775.86M	726.5M
Total Current Assets	569.81M	492.13M	431.02M	410.52M	438.14M	343.62M	522.38M	474.17M
Cash and Equivalents	549.91M	473.15M	405.87M	387.32M	391.57M	296.33M	474.34M	427.65M
Total Non-Current Assets	219.67M	225.25M	325.45M	306.55M	302.07M	300.95M	308.56M	309.84M
Total Liabilities	215.48M	197.19M	197.74M	192.86M	190.26M	156.7M	191.41M	201.94M
Total Current Liabilities	100.27M	92.15M	113.96M	94.12M	93.17M	73.92M	86.08M	108.89M
Total Non-Current Liabilities	115.75M	106.22M	84.93M	99.87M	98.19M	83.85M	128.25M	113.56M
Common Equity	2k	2k	2k	2k	2k	2k	3k	3k
Retained Earnings	-639.56M	-704.88M	-781.61M	-874.63M	-967.62M	-1.06B	-1.16B	-1.25B

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	101.43M	298.59M	610.35M	701.29M	653.7M
Total Current Assets	76.4M	269.48M	534.72M	569.81M	438.14M
Cash and Equivalents	69.88M	262.13M	285.12M	549.91M	391.57M
Total Non-Current Assets	-124.27M	-206.29M	542.94M	485.81M	463.44M
Total Liabilities	24.59M	56.56M	67.41M	215.48M	190.26M
Total Current Liabilities	6.68M	23.1M	46.66M	100.27M	93.17M
Total Non-Current Liabilities	30.32M	44.88M	21.38M	115.75M	98.19M
Total Equity	-124.27M	-206.29M	542.94M	485.81M	463.44M
Common Equity	2.33M	7.31M	2k	2k	2k
Retained Earnings	0	0	-400.08M	-639.56M	-967.62M